^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^Breitbart RE, Liang CS, Smoot LB, Laheru DA, Mahdavi V, Nadal-Ginard B (Aug 1993). "A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage".Development.118 (4):1095–1106.doi:10.1242/dev.118.4.1095.PMID8269842.
^Youn HD, Sun L, Prywes R, Liu JO (Oct 1999). "Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2".Science.286 (5440):790–793.doi:10.1126/science.286.5440.790.PMID10531067.
^Park SY, Shin HM, Han TH (Sep 2002). "Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter".Molecular Immunology.39 (1–2):25–30.doi:10.1016/s0161-5890(02)00055-x.PMID12213324.
Hobson GM, Krahe R, Garcia E, Siciliano MJ, Funanage VL (Oct 1995). "Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23".Genomics.29 (3):704–711.doi:10.1006/geno.1995.9007.PMID8575763.
Park SY, Shin HM, Han TH (Sep 2002). "Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter".Molecular Immunology.39 (1–2):25–30.doi:10.1016/S0161-5890(02)00055-X.PMID12213324.